Leo Price,
CEO
Leo Price was trained as a cell biologist and has held positions in London, San Diego, Amsterdam and Utrecht in cancer research. From 2005, he ran a research group at Leiden University, where he developed 3D tissue culture based screening technology. This technology was spun off as OcellO, a contract research company that develops physiologically relevant models of disease and uses these to offer compound screening and profiling services for the drug discovery industry.
|
|
|